Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Missense polymorphisms in matrix metalloproteinase genes and skin cancer risk.

Nan H, Niu T, Hunter DJ, Han J.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3551-7. doi: 10.1158/1055-9965.EPI-08-0606.

2.

Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.

Nan H, Kraft P, Hunter DJ, Han J.

Int J Cancer. 2009 Aug 15;125(4):909-17. doi: 10.1002/ijc.24327.

3.

XPA, haplotypes, and risk of basal and squamous cell carcinoma.

Miller KL, Karagas MR, Kraft P, Hunter DJ, Catalano PJ, Byler SH, Nelson HH.

Carcinogenesis. 2006 Aug;27(8):1670-5. Epub 2006 Mar 2.

PMID:
16513681
4.

Polymorphisms in DNA double-strand break repair genes and skin cancer risk.

Han J, Colditz GA, Samson LD, Hunter DJ.

Cancer Res. 2004 May 1;64(9):3009-13.

5.

Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk.

Nan H, Qureshi AA, Hunter DJ, Han J.

Br J Dermatol. 2008 Aug;159(2):314-21. doi: 10.1111/j.1365-2133.2008.08624.x. Epub 2008 May 28.

6.

A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus.

Han J, Qureshi AA, Nan H, Zhang J, Song Y, Guo Q, Hunter DJ.

Cancer Res. 2011 Mar 1;71(5):1533-9. doi: 10.1158/0008-5472.CAN-10-1818. Epub 2011 Jan 26.

7.

CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer.

Welsh MM, Applebaum KM, Spencer SK, Perry AE, Karagas MR, Nelson HH.

Cancer Res. 2009 Aug 1;69(15):6158-63. doi: 10.1158/0008-5472.CAN-09-0415. Epub 2009 Jul 21.

8.

Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study.

Nan H, Qureshi AA, Hunter DJ, Han J.

BMC Cancer. 2009 Jun 6;9:172. doi: 10.1186/1471-2407-9-172.

9.

Polymorphisms in the DNA repair gene XRCC1 associated with basal cell carcinoma and squamous cell carcinoma of the skin in a Korean population.

Kang SY, Lee KG, Lee W, Shim JY, Ji SI, Chung KW, Chung YK, Kim NK.

Cancer Sci. 2007 May;98(5):716-20. Epub 2007 Mar 9.

10.

Genetic variants in telomere-maintaining genes and skin cancer risk.

Nan H, Qureshi AA, Prescott J, De Vivo I, Han J.

Hum Genet. 2011 Mar;129(3):247-53. doi: 10.1007/s00439-010-0921-5. Epub 2010 Nov 30.

11.

Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma.

Nan H, Xu M, Kraft P, Qureshi AA, Chen C, Guo Q, Hu FB, Curhan G, Amos CI, Wang LE, Lee JE, Wei Q, Hunter DJ, Han J.

Hum Mol Genet. 2011 Sep 15;20(18):3718-24. doi: 10.1093/hmg/ddr287. Epub 2011 Jun 23.

12.
13.

RNASEL and MIR146A SNP-SNP interaction as a susceptibility factor for non-melanoma skin cancer.

Farzan SF, Karagas MR, Christensen BC, Li Z, Kuriger JK, Nelson HH; New Hampshire Skin Cancer Study.

PLoS One. 2014 Apr 3;9(4):e93602. doi: 10.1371/journal.pone.0093602. eCollection 2014.

14.

Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population.

Jin G, Miao R, Hu Z, Xu L, Huang X, Chen Y, Tian T, Wei Q, Boffetta P, Shen H.

Int J Cancer. 2009 May 1;124(9):2172-8. doi: 10.1002/ijc.24190.

15.

Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.

Saracini C, Bolli P, Sticchi E, Pratesi G, Pulli R, Sofi F, Pratesi C, Gensini GF, Abbate R, Giusti B.

J Vasc Surg. 2012 Jan;55(1):171-179.e2. doi: 10.1016/j.jvs.2011.07.051. Epub 2011 Nov 16.

16.

Height, height-related SNPs, and risk of non-melanoma skin cancer.

Li X, Liang L, Feng YA, De Vivo I, Giovannucci E, Tang JY, Han J.

Br J Cancer. 2017 Jan 3;116(1):134-140. doi: 10.1038/bjc.2016.366. Epub 2016 Nov 15.

17.

Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire.

Applebaum KM, Karagas MR, Hunter DJ, Catalano PJ, Byler SH, Morris S, Nelson HH.

Environ Health Perspect. 2007 Aug;115(8):1231-6.

18.

[Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].

Fu XR, Zhang C, Chen CY, Zhang L, Wang LX, Wang BH, Liu XY, Zhang MZ.

Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):369-73. doi: 10. 3760/cma.j.issn.0253-3766.2012.05.011. Chinese.

PMID:
22883459
19.

Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study.

Slattery ML, John E, Torres-Mejia G, Stern M, Lundgreen A, Hines L, Giuliano A, Baumgartner K, Herrick J, Wolff RK.

PLoS One. 2013 May 16;8(5):e63165. doi: 10.1371/journal.pone.0063165. Print 2013.

20.

Pre-diagnostic leukocyte mitochondrial DNA copy number and skin cancer risk.

Meng S, De Vivo I, Liang L, Giovannucci E, Tang JY, Han J.

Carcinogenesis. 2016 Sep;37(9):897-903. doi: 10.1093/carcin/bgw072. Epub 2016 Jul 5.

Supplemental Content

Support Center